Long-Term Liabilities: The sum of all non-current liabilities.
Eupraxia Pharmaceuticals Inc. (EPRX) Long-Term Liabilities data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-9.38M |
|
-- |
|
-- |
|
$8.26M |
|
$-8.26M |
|
$-0.48M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-8.75M |
|
$-8.74M |
|
$-8.26M |
|
$-8.26M |
|
35.91M |
|
35.91M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$22.83M |
|
$0.66M |
|
$0.77M |
|
$23.60M |
|
$2.62M |
|
-- |
|
|
Long-Term Liabilities |
-- |
$2.62M |
|
$-10.73M |
|
$20.98M |
|
$20.98M |
|
35.96M |
|
| Cash Flow Statement Financials | |
$-14.32M |
|
$-0.34M |
|
$0.67M |
|
$33.10M |
|
$19.77M |
|
$-13.34M |
|
$2.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.72 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
81.44% |
|
-41.65% |
|
-37.03% |
|
-41.65% |
|
$0.58 |
|
$-0.41 |
|
$-0.40 |
|